EE333 Evaluating the Long-Term Clinical, Societal, and Economic Outcomes of Ofatumumab vs Teriflunomide/Interferon Β-1A and the Impact of Early vs Delayed Ofatumumab Initiation in Relapsing Multiple Sclerosis Patients in Greece
Abstract
Authors
A Petropoulos U Vudumula M Patidar S Tiwari R Brennan K Kapsogeorgiou G Cheilas J Banhazi